Search Results 561-570 of 18599 for alopecia
... Alopecia areata, Seborrheic dermatitis, Melasma, Vitiligo. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann ...
... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...
- All grades of alopecia are acceptable - Endocrine dysfunction on replacement therapy is acceptable - Severe or unstable medical condition, including ...
CTC grade 4 non-hematological Toxicity (except for alopecia, nausea, vomiting);; Significant liver function impairment - AST or ALT > 3 times the upper limit ...
... alopecia. * Autologous stem cell transplantation within 100 days of this study for post autologous transplant individuals. * Residual symptoms of ...
Patients must have recovered sufficiently from all acute adverse effects of prior therapies, excluding alopecia. Patients must have an ECOG performance ...
Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn., Albert Lea, Minn ...
... alopecia or peripheral neuropathy. Have discontinued all previous therapies for cancer (including chemotherapy, radiotherapy, immunotherapy, and endocrine ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.